Phosphatidylserine IgG Test | Antiphospholipid Screen
Uncover a hidden driver of clotting and pregnancy loss.
The Phosphatidylserine IgG Test measures antibodies directed against phosphatidylserine, a phospholipid that normally helps regulate blood clotting and cellular signalling. This test is typically requested as part of an antiphospholipid screen when there is clinical suspicion of antiphospholipid syndrome (APS), a condition in which the immune system mistakenly targets phospholipids and phospholipid-binding proteins. It is also used in the investigation of recurrent thrombosis, unexplained pregnancy loss, thrombocytopenia, or a prolonged clotting time. The test may be particularly relevant for individuals with a history of venous or arterial blood clots, recurrent miscarriage, or autoimmune conditions such as systemic lupus erythematosus (SLE).
Phospholipid Antibodies
- Phosphatidylserine IgG antibody (Anti-PS IgG)
Why it matters
Phosphatidylserine IgG antibodies are one of several antiphospholipid antibodies that can increase the risk of abnormal blood clotting and pregnancy complications. Identifying these antibodies helps clinicians confirm or exclude antiphospholipid syndrome, guiding appropriate management and monitoring. Early detection can inform decisions about anticoagulation and pregnancy care, reducing the risk of serious thrombotic events and improving outcomes.
Phospholipid Antibodies
- Phosphatidylserine IgG antibody (Anti-PS IgG)
No special preparation required.
For blood tests, we recommend drinking plenty of water beforehand to ensure smooth sample collection. If you are taking any regular medication, continue to do so unless advised otherwise by your doctor.
Important Clinical Information:
This test is a screening tool to monitor and support your overall health. It does not replace your GP or consultant.
Always discuss your test results, especially any abnormal results, with your GP, who can interpret them in the context of your medical history and overall health.